Literature DB >> 3169743

Orosomucoid (alpha-1 acid glycoprotein) phenotyping by use of immobilized pH gradients with 8 M urea and immunoblotting. A new variant encountered in a population study.

C B Eap1, C Cuendet, P Baumann.   

Abstract

Orosomucoid (ORM) phenotyping has been performed on 329 unrelated Swiss subjects, using immobilized pH gradients with 8 M urea and 2% v/v 2-mercaptoethanol followed by immunoblotting. After desialylation the band patterns of ORM confirmed that the polymorphism of the structural locus ORM1 is controlled by three codominant autosomal alleles (ORM1*F1, ORM1*S and ORM1*F2). One rare and one new allele were detected. The rare variant, tentatively assigned to the second structural locus ORM2, is observed in a cathodal position and named ORM2 B1. The new variant, tentatively assigned to the first structural locus ORM1, is observed in a region located between ORM1 S and ORM1 F2, and named ORM1 F3. Moreover, the pI values of the ORM variants have been measured accurately with Immobiline Dry Plates (LKB): they were found to be within the pH range 4.93-5.14.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169743     DOI: 10.1007/bf00702865

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  VARIANTS OF ALPHA-1-ACID GLYCOPROTEIN.

Authors:  K TOKITA; K SCHMID
Journal:  Nature       Date:  1963-10-19       Impact factor: 49.962

2.  Structure of the human alpha 1-acid glycoprotein gene: sequence homology with other human acute phase protein genes.

Authors:  L Dente; G Ciliberto; R Cortese
Journal:  Nucleic Acids Res       Date:  1985-06-11       Impact factor: 16.971

3.  Mapping through somatic cell hybrids and cDNA probes of protein C to chromosome 2, factor X to chromosome 13, and alpha 1-acid glycoprotein to chromosome 9.

Authors:  M Rocchi; L Roncuzzi; R Santamaria; N Archidiacono; L Dente; G Romeo
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

4.  Isoelectric focusing of alpha-1 acid glycoprotein (orosomucoid) in immobilized pH-gradients with 8M urea: detection of its desialylated variants using an alkaline phosphatase-linked secondary antibody system.

Authors:  C B Eap; P Baumann
Journal:  Electrophoresis       Date:  1988-10       Impact factor: 3.535

5.  Isoelectric focusing of proteins in the native and denatured states. Anomalous behaviour of plasma albumin.

Authors:  M R Salaman; A R Williamson
Journal:  Biochem J       Date:  1971-03       Impact factor: 3.857

6.  Inheritance of human alpha-1-acid glycoprotein (orosomucoid) variants.

Authors:  A M Johnson; K Schmid; C A Alper
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

7.  Three new orosomucoid (ORM) variants revealed by isoelectric focusing and print immunofixation.

Authors:  S Weidinger; T Müller; F Schwarzfischer; H Cleve
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

8.  Genetic studies of low-abundance human plasma proteins. V. Evidence for a second orosomucoid structural locus (ORM2) expressed in plasma.

Authors:  M H Escallon; R E Ferrell; M I Kamboh
Journal:  Am J Hum Genet       Date:  1987-09       Impact factor: 11.025

9.  Direct assignment of orosomucoid to human chromosome 9 and alpha 2HS-glycoprotein to chromosome 3 using human fetal liver x rat hepatoma hybrids.

Authors:  D W Cox; U Francke
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  Leukocyte surface origin of human alpha1-acid glycoprotein (orosomucoid).

Authors:  C G Gahmberg; L C Andersson
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  5 in total

1.  Genetic polymorphism of orosomucoid (ORM1 and ORM2) in Lombardy (Italy).

Authors:  N Cerri; F De Ferrari
Journal:  Int J Legal Med       Date:  1992       Impact factor: 2.686

2.  Inflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice.

Authors:  W van Dijk; O Pos; M E van der Stelt; H J Moshage; S H Yap; L Dente; P Baumann; C B Eap
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

Review 3.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Orosomucoid (ORM 1) subtyping and formal genetics.

Authors:  C Luckenbach; J Kömpf; H Ritter
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

Review 5.  Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.

Authors:  Sherri A Smith; Nigel J Waters
Journal:  Pharm Res       Date:  2018-12-28       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.